Involvement of nerve growth factor (NGF) in chronic neuropathic pain – a systematic review

References

Aloe, L. (2011). Rita Levi-Montalcini and the discovery of NGF, the first nerve cell growth factor. Arch. Ital. Biol. 149: 175–181. https://doi.org/10.4449/aib.v149i2.1377.Suche in Google Scholar PubMed

Bannister, K., Sachau, J., Baron, R., and Dickenson, A.H. (2020). Neuropathic pain: mechanism-based therapeutics. Annu. Rev. Pharmacol. Toxicol. 60: 257–274. https://doi.org/10.1146/annurev-pharmtox-010818-021524.Suche in Google Scholar PubMed

Bannwarth, B. and Kostine, M. (2014). Targeting nerve growth factor (NGF) for pain management: what does the future hold for NGF antagonists? Drugs 74: 619–626. https://doi.org/10.1007/s40265-014-0208-6.Suche in Google Scholar PubMed

Baron, R., Binder, A., and Wasner, G. (2010). Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 9: 807–819. https://doi.org/10.1016/s1474-4422(10)70143-5.Suche in Google Scholar PubMed

Belliveau, D.J., Krivko, I., Kohn, J., Lachance, C., Pozniak, C., Rusakov, D., Kaplan, D., and Miller, F.D. (1997). NGF and neurotrophin-3 both activate TrkA on sympathetic neurons but differentially regulate survival and neuritogenesis. J. Cell Biol. 136: 375–388. https://doi.org/10.1083/jcb.136.2.375.Suche in Google Scholar PubMed PubMed Central

Bouhassira, D., Lanteri-Minet, M., Attal, N., Laurent, B., and Touboul, C. (2008). Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 136: 380–387. https://doi.org/10.1016/j.pain.2007.08.013.Suche in Google Scholar PubMed

Brown, M.T., Murphy, F.T., Radin, D.M., Davignon, I., Smith, M.D., and West, C.R. (2012). Tanezumab reduces osteoarthritic knee pain: results of a randomized, double-blind, placebo-controlled phase III trial. J. Pain 13: 790–798. https://doi.org/10.1016/j.jpain.2012.05.006.Suche in Google Scholar PubMed

Cattaneo, A. (2010). Tanezumab, a recombinant humanized mAb against nerve growth factor for the treatment of acute and chronic pain. Curr. Opin. Mol. Therapeut. 12: 94–106.Suche in Google Scholar

Cirillo, G., Cavaliere, C., Bianco, M.R., De Simone, A., Colangelo, A.M., Sellitti, S., Alberghina, L., and Papa, M. (2010). Intrathecal NGF administration reduces reactive astrocytosis and changes neurotrophin receptors expression pattern in a rat model of neuropathic pain. Cell. Mol. Neurobiol. 30: 51–62. https://doi.org/10.1007/s10571-009-9430-2.Suche in Google Scholar PubMed

Cohen, S., Levi-Montalcini, R., and Hamburger, V. (1954). A nerve growth-stimulating factor isolated from Sarcom as 37 and 180. Proc. Natl. Acad. Sci. U.S.A. 40: 1014–1018. https://doi.org/10.1073/pnas.40.10.1014.Suche in Google Scholar PubMed PubMed Central

Covaceuszach, S., Marinelli, S., Krastanova, I., Ugolini, G., Pavone, F., Lamba, D., and Cattaneo, A. (2012). Single cycle structure-based humanization of an anti-nerve growth factor therapeutic antibody. PLoS One 7: e32212. https://doi.org/10.1371/journal.pone.0032212.Suche in Google Scholar PubMed PubMed Central

Dai, W.L., Yan, B., Bao, Y.N., Fan, J.F., and Liu, J.H. (2020). Suppression of peripheral NGF attenuates neuropathic pain induced by chronic constriction injury through the TAK1-MAPK/NF-κB signaling pathways. Cell Commun. Signal. 18: 66. https://doi.org/10.1186/s12964-020-00556-3.Suche in Google Scholar PubMed PubMed Central

Da Silva, J.T., Evangelista, B.G., Venega, R.A.G., Seminowicz, D.A., and Chacur, M. (2019). Anti-NGF treatment can reduce chronic neuropathic pain by changing peripheral mediators and brain activity in rats. Behav. Pharmacol. 30: 79–88. https://doi.org/10.1097/fbp.0000000000000422.Suche in Google Scholar

Deng, Y.S., Zhong, J.H., and Zhou, X.F. (2000). Effects of endogenous neurotrophins on sympathetic sprouting in the dorsal root ganglia and allodynia following spinal nerve injury. Exp. Neurol. 164: 344–350. https://doi.org/10.1006/exnr.2000.7432.Suche in Google Scholar PubMed

Denk, F., Bennett, D.L., and McMahon, S.B. (2017). Nerve growth factor and pain mechanisms. Annu. Rev. Neurosci. 40: 307–325. https://doi.org/10.1146/annurev-neuro-072116-031121.Suche in Google Scholar PubMed

Djouhri, L. (2016). PG110, A humanized anti-NGF antibody, reverses established pain hypersensitivity in persistent inflammatory pain, but not peripheral neuropathic pain, rat models. Pain Med. 17: 2082–2094. https://doi.org/10.1093/pm/pnw007.Suche in Google Scholar PubMed

Evans, R.J., Moldwin, R.M., Cossons, N., Darekar, A., Mills, I.W., and Scholfield, D. (2011). Proof of concept trial of tanezumab for the treatment of symptoms associated with interstitial cystitis. J. Urol. 185: 1716–1721. https://doi.org/10.1016/j.juro.2010.12.088.Suche in Google Scholar PubMed

Finnerup, N.B., Sindrup, S.H., and Jensen, T.S. (2010). The evidence for pharmacological treatment of neuropathic pain. Pain 150: 573–581. https://doi.org/10.1016/j.pain.2010.06.019.Suche in Google Scholar PubMed

Gallo, G. and Letourneau, P.C. (1998). Localized sources of neurotrophins initiate axon collateral sprouting. J. Neurosci. 18: 5403–5414. https://doi.org/10.1523/jneurosci.18-14-05403.1998.Suche in Google Scholar PubMed PubMed Central

Ghilardi, J.R., Freeman, K.T., Jimenez-Andrade, J.M., Coughlin, K.A., Kaczmarska, M.J., Castaneda-Corral, G., Bloom, A.P., Kuskowski, M.A., and Mantyh, P.W. (2012). Neuroplasticity of sensory and sympathetic nerve fibers in a mouse model of a painful arthritic joint. Arthritis Rheum. 64: 2223–2232. https://doi.org/10.1002/art.34385.Suche in Google Scholar PubMed PubMed Central

Guerios, S.D., Wang, Z.Y., and Bjorling, D.E. (2006). Nerve growth factor mediates peripheral mechanical hypersensitivity that accompanies experimental cystitis in mice. Neurosci. Lett. 392: 193–197. https://doi.org/10.1016/j.neulet.2005.09.026.Suche in Google Scholar PubMed

Hefti, F. (2020). Pharmacology of nerve growth factor and discovery of tanezumab, an anti-nerve growth factor antibody and pain therapeutic. Pharmacol. Res. 154: 104240. https://doi.org/10.1016/j.phrs.2019.04.024.Suche in Google Scholar PubMed

Herzberg, U., Eliav, E., Dorsey, J.M., Gracely, R.H., and Kopin, I.J. (1997). NGF involvement in pain induced by chronic constriction injury of the rat sciatic nerve. Neuroreport 8: 1613–1618. https://doi.org/10.1097/00001756-199705060-00012.Suche in Google Scholar PubMed

Hooijmans, C.R., Rovers, M.M., de Vries, R.B., Leenaars, M., Ritskes-Hoitinga, M., and Langendam, M.W. (2014). SYRCLE’s risk of bias tool for animal studies. BMC Med. Res. Methodol. 14: 43. https://doi.org/10.1186/1471-2288-14-43.Suche in Google Scholar PubMed PubMed Central

Hu, V.Y., Zvara, P., Dattilio, A., Redman, T.L., Allen, S.J., Dawbarn, D., Stroemer, R.P., and Vizzard, M.A. (2005). Decrease in bladder overactivity with REN1820 in rats with cyclophosphamide induced cystitis. J. Urol. 173: 1016–1021. https://doi.org/10.1097/01.ju.0000155170.15023.e5.Suche in Google Scholar PubMed

Ivanisevic, L., Zheng, W., Woo, S.B., Neet, K.E., and Saragovi, H.U. (2007). TrkA receptor “hot spots” for binding of NT-3 as a heterologous ligand. J. Biol. Chem. 282: 16754–16763. https://doi.org/10.1074/jbc.m701996200.Suche in Google Scholar PubMed

Jaggar, S.I., Scott, H.C., and Rice, A.S. (1999). Inflammation of the rat urinary bladder is associated with a referred thermal hyperalgesia which is nerve growth factor dependent. Br. J. Anaesth. 83: 442–448. https://doi.org/10.1093/bja/83.3.442.Suche in Google Scholar PubMed

Jensen, T.S., Baron, R., Haanpaa, M., Kalso, E., Loeser, J.D., Rice, A.S.C., and Treede, R.D. (2011). A new definition of neuropathic pain. Pain 152: 2204–2205. https://doi.org/10.1016/j.pain.2011.06.017.Suche in Google Scholar PubMed

Jimenez-Andrade, J.M., Bloom, A.P., Stake, J.I., Mantyh, W.G., Taylor, R.N., Freeman, K.T., Ghilardi, J.R., Kuskowski, M.A., and Mantyh, P.W. (2010). Pathological sprouting of adult nociceptors in chronic prostate cancer-induced bone pain. J. Neurosci. 30: 14649–14656. https://doi.org/10.1523/jneurosci.3300-10.2010.Suche in Google Scholar

Jones, M.R., Viswanath, O., Peck, J., Kaye, A.D., Gill, J.S., and Simopoulos, T.T. (2018). A brief history of the opioid epidemic and strategies for pain medicine. Pain Ther 7: 13–21. https://doi.org/10.1007/s40122-018-0097-6.Suche in Google Scholar PubMed PubMed Central

Ju, H., Feng, Y., Gao, Z., and Yang, B.X. (2012). The potential role of nerve growth factor in cryoneurolysis-induced neuropathic pain in rats. Cryobiology 65: 132–138. https://doi.org/10.1016/j.cryobiol.2012.04.009.Suche in Google Scholar PubMed

Katz, N., Borenstein, D.G., Birbara, C., Bramson, C., Nemeth, M.A., Smith, M.D., and Brown, M.T. (2011). Efficacy and safety of tanezumab in the treatment of chronic low back pain. Pain 152: 2248–2258. https://doi.org/10.1016/j.pain.2011.05.003.Suche in Google Scholar PubMed

Kosai, K., Terayama, R., Ikeda, T., Uno, T., Nishimori, T., and Takasaki, M. (2001). Local infusion of nerve growth factor attenuates myelinated nerve fiber sprouting into lamina II of the spinal dorsal horn and reduces the increased responsiveness to mechanical stimuli in rats with chronic constriction nerve injury. J. Anesth. 15: 210–216, doi:https://doi.org/10.1007/s005400170005.Suche in Google Scholar PubMed

Lane, N.E., Schnitzer, T.J., Birbara, C.A., Mokhtarani, M., Shelton, D.L., Smith, M.D., and Brown, M.T. (2010). Tanezumab for the treatment of pain from osteoarthritis of the knee. N. Engl. J. Med. 363: 1521–1531. https://doi.org/10.1056/nejmoa0901510.Suche in Google Scholar

Levi-Montalcini, R. and Hamburger, V. (1951). Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo. J. Exp. Zool. 116: 321–361. https://doi.org/10.1002/jez.1401160206.Suche in Google Scholar PubMed

Levi-Montalcini, R., Meyer, H., and Hamburger, V. (1954). In vitro experiments on the effects of mouse sarcomas 180 and 37 on the spinal and sympathetic ganglia of the chick embryo. Cancer Res. 14: 49–57.10.1142/9789812830319_0007Suche in Google Scholar

Longo, G., Osikowicz, M., and Ribeiro-da-Silva, A. (2013). Sympathetic fiber sprouting in inflamed joints and adjacent skin contributes to pain-related behavior in arthritis. J. Neurosci. 33: 10066–10074. https://doi.org/10.1523/jneurosci.5784-12.2013.Suche in Google Scholar PubMed PubMed Central

Ma, W.Y., Murata, E., Ueda, K., Kuroda, Y., Cao, M.H., Abe, M., Shigemi, K., and Hirose, M. (2010). A synthetic cell-penetrating peptide antagonizing TrkA function suppresses neuropathic pain in mice. J. Pharmacol. Sci. 114: 79–84. https://doi.org/10.1254/jphs.10119fp.Suche in Google Scholar PubMed

Matsuura, Y., Iwakura, N., Ohtori, S., Suzuki, T., Kuniyoshi, K., Murakami, K., Hiwatari, R., Hashimoto, K., Okamoto, S., Shibayama, M., et al.. (2013). The effect of anti-NGF receptor (p75 neurotrophin receptor) antibodies on nociceptive behavior and activation of spinal microglia in the rat brachial plexus avulsion model. Spine 38: E332–E338. https://doi.org/10.1097/brs.0b013e318285ee20.Suche in Google Scholar PubMed

Nickel, J.C., Mills, I.W., Crook, T.J., Jorga, A., Smith, M.D., Atkinson, G., and Krieger, J.N. (2016). Tanezumab reduces pain in women with interstitial cystitis/bladder pain syndrome and patients with nonurological associated somatic syndromes. J. Urol. 195: 942–948. https://doi.org/10.1016/j.juro.2015.10.178.Suche in Google Scholar PubMed

Nocchi, L., Portulano, C., Franciosa, F., Doleschall, B., Panea, M., Roy, N., Maffei, M., Gargano, A., Perlas, E., and Heppenstall, P.A. (2019). Nerve growth factor-mediated photoablation of nociceptors reduces pain behavior in mice. Pain 160: 2305–2315. https://doi.org/10.1097/j.pain.0000000000001620.Suche in Google Scholar PubMed PubMed Central

Petrie, C.N., Armitage, M.N., and Kawaja, M.D. (2015). Myenteric expression of nerve growth factor and the p75 neurotrophin receptor regulate axonal remodeling as a consequence of colonic inflammation in mice. Exp. Neurol. 271: 228–240. https://doi.org/10.1016/j.expneurol.2015.06.010.Suche in Google Scholar PubMed

Pezet, S. and McMahon, S.B. (2006). Neurotrophins: mediators and modulators of pain. Annu. Rev. Neurosci. 29: 507–538. https://doi.org/10.1146/annurev.neuro.29.051605.112929.Suche in Google Scholar PubMed

Quintão, N.L., Santos, A.R., Campos, M.M., and Calixto, J.B. (2008). The role of neurotrophic factors in genesis and maintenance of mechanical hypernociception after brachial plexus avulsion in mice. Pain 136: 125–133. https://doi.org/10.1016/j.pain.2007.06.027.Suche in Google Scholar PubMed

Raja, S.N., Carr, D.B., Cohen, M., Finnerup, N.B., Flor, H., Gibson, S., Keefe, F.J., Mogil, J.S., Ringkamp, M., Sluka, K.A., et al.. (2020). The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises. Pain 161: 1976–1982. https://doi.org/10.1097/j.pain.0000000000001939.Suche in Google Scholar PubMed PubMed Central

Ramer, M.S., Kawaja, M.D., Henderson, J.T., Roder, J.C., and Bisby, M.A. (1998). Glial overexpression of NGF enhances neuropathic pain and adrenergic sprouting into DRG following chronic sciatic constriction in mice. Neurosci. Lett. 251: 53–56. https://doi.org/10.1016/s0304-3940(98)00493-5.Suche in Google Scholar PubMed

Ren, K., Thomas, D.A., and Dubner, R. (1995). Nerve growth factor alleviates a painful peripheral neuropathy in rats. Brain Res. 699: 286–292. https://doi.org/10.1016/0006-8993(95)00920-l.Suche in Google Scholar PubMed

Ro, L.S., Chen, S.T., Tang, L.M., and Jacobs, J.M. (1999). Effect of NGF and anti-NGF on neuropathic pain in rats following chronic constriction injury of the sciatic nerve. Pain 79: 265–274. https://doi.org/10.1016/s0304-3959(98)00164-x.Suche in Google Scholar PubMed

Rocco, M.L., Soligo, M., Manni, L., and Aloe, L. (2018). Nerve growth factor: early studies and recent clinical trials. Curr. Neuropharmacol. 16: 1455–1465. https://doi.org/10.2174/1570159x16666180412092859.Suche in Google Scholar

Sabsovich, I., Wei, T., Guo, T.Z., Zhao, R., Shi, X., Li, X., Yeomans, D.C., Klyukinov, M., Kingery, W.S., and Clark, D.J. (2008). Effect of anti-NGF antibodies in a rat tibia fracture model of complex regional pain syndrome type I. Pain 138: 47–60. https://doi.org/10.1016/j.pain.2007.11.004.Suche in Google Scholar PubMed PubMed Central

Schnitzer, T.J., Easton, R., Pang, S., Levinson, D.J., Pixton, G., Viktrup, L., Davignon, I., Brown, M.T., West, C.R., and Verburg, K.M. (2019). Effect of tanezumab on joint pain, physical function, and patient global assessment of osteoarthritis among patients with osteoarthritis of the hip or knee: a randomized clinical trial. J. Am. Med. Assoc. 322: 37–48. https://doi.org/10.1001/jama.2019.8044.Suche in Google Scholar PubMed PubMed Central

St John Smith, E. (2018). Advances in understanding nociception and neuropathic pain. J. Neurol. 265: 231–238. https://doi.org/10.1007/s00415-017-8641-6.Suche in Google Scholar PubMed PubMed Central

Stanzel, R.D., Lourenssen, S., and Blennerhassett, M.G. (2008). Inflammation causes expression of NGF in epithelial cells of the rat colon. Exp. Neurol. 211: 203–213. https://doi.org/10.1016/j.expneurol.2008.01.028.Suche in Google Scholar PubMed

Thompson, S.W.N., Dray, A., McCarson, K.E., Krause, J.E., and Urban, L. (1995). Nerve growth factor induces mechanical allodynia associated with novel A fibre-evoked spinal reflex activity and enhanced neurokinin-1 receptor activation in the rat. Pain 62: 219–231. https://doi.org/10.1016/0304-3959(94)00271-f.Suche in Google Scholar PubMed

Ugolini, G., Marinelli, S., Covaceuszach, S., Cattaneo, A., and Pavone, F. (2007). The function neutralizing anti-TrkA antibody MNAC13 reduces inflammatory and neuropathic pain. Proc. Natl. Acad. Sci. U.S.A. 104: 2985–2990. https://doi.org/10.1073/pnas.0611253104.Suche in Google Scholar PubMed PubMed Central

van Hecke, O., Kamerman, P.R., Attal, N., Baron, R., Bjornsdottir, G., Bennett, D.L.H., Bennett, M.I., Bouhassira, D., Diatchenko, L., Freeman, R., et al.. (2015). Neuropathic pain phenotyping by international consensus (NeuroPPIC) for genetic studies: a NeuPSIG systematic review, Delphi survey, and expert panel recommendations. Pain 156: 2337–2353. https://doi.org/10.1097/j.pain.0000000000000335.Suche in Google Scholar PubMed PubMed Central

Wakabayashi, Y., Maeda, T., and Kwok, Y.N. (1996). Increase of p75 immunoreactivity in rat urinary bladder following inflammation. Neuroreport 7: 1141–1144. https://doi.org/10.1097/00001756-199604260-00008.Suche in Google Scholar PubMed

Wang, H., Russell, L.J., Kelly, K.M., Wang, S., and Thipphawong, J. (2017). Fulranumab in patients with interstitial cystitis/bladder pain syndrome: observations from a randomized, double-blind, placebo-controlled study. BMC Urol. 17: 2. https://doi.org/10.1186/s12894-016-0193-z.Suche in Google Scholar PubMed PubMed Central

Wild, K.D., Bian, D., Zhu, D., Davis, J., Bannon, A.W., Zhang, T.J., and Louis, J.C. (2007). Antibodies to nerve growth factor reverse established tactile allodynia in rodent models of neuropathic pain without tolerance. J. Pharmacol. Exp. Ther. 322: 282–287, doi:https://doi.org/10.1124/jpet.106.116236.Suche in Google Scholar PubMed

Zhou, X.F., Deng, Y.S., Xian, C.J., and Zhong, J.H. (2000). Neurotrophins from dorsal root ganglia trigger allodynia after spinal nerve injury in rats. Eur. J. Neurosci. 12: 100–105. https://doi.org/10.1046/j.1460-9568.2000.00884.x.Suche in Google Scholar PubMed